🥜🦀 A research group @jourdainlab.bsky.social @dib-unil.bsky.social @fbm-unil.bsky.social @unil.bsky.social has identified a new mechanism that exposes the vulnerability of #tumor #cells when they are deprived of #vitamin B7, also known as #biotin.
Press release here 👉 www.unil.ch/news/en/1770...
Posts by Alexis A. Jourdain
Our story on #FBXW7 and #biotin in #glutamine_addiction is now peer-reviewed and published in Molecular Cell! Heroic work led by the very first postdoc of the lab @miriamlisci.bsky.social. Have a look!
www.cell.com/molecular-ce...
Happy to share that the our manuscript "Cyclin CLB2 mRNA localization and protein synthesis link cell cycle progression to bud growth" is now finally out in its final form @natcomms.nature.com
www.nature.com/articles/s41...
Below a short🧵 with the key findings!
10 days left to apply! 👇
One month left to apply to the open postdoc position in our lab! 👇
👏 Bravo à Alexis Jourdain qui rejoindra l’EMBO Young Investigator Programme @embo.org au 1er janvier 2026. L’initiative européenne soutient des scientifiques en début de carrière dirigeant leur propre équipe de recherche.
🔗 www.unil.ch/news/fr/1764...
@jourdainlab.bsky.social @dib-unil.bsky.social
Thrilled and incredibly honored to be selected as an @embo.org Young Investigator! Still can’t quite believe it 🎉 Huge thanks to EMBO and to all the amazing mentors, colleagues, and collaborators who made this possible!
@fbm-unil.bsky.social
@unil.bsky.social
@snsf.ch
Rich collections of papers on #mitochondrialdisease from the last 2 weeks! 📚
biomed.news/bims-mitdis/...
biomed.news/bims-mitdis/...
@biomednews.bsky.social @mitoscientist.bsky.social
@gavinmcstay.bsky.social
Demethoxy-CoQ and NUDT5 in nucleotide synthesis
www.nature.com/articles/s42...
Very excited to announce that the first paper from the lab is now live @natcomms.nature.com #mitochondria #immunometabolism
This work was led by postdoc Eloise marques with many important contributions from all of our co-authors.
Please check it out!
www.nature.com/articles/s41...
We are hiring a postdoc! 🧪
▶️ Project: nucleotide metabolism (genomics & biochemistry)
▶️ Start date: spring 2026 (flexible)
▶️ More info and application: tinyurl.com/3kjrbb2x
Please share 🌏
@fbm-unil.bsky.social @dib-unil.bsky.social @unil.bsky.social @snsf.ch
Good Sunday!. A wonderful selection of papers in #cancermetabolism and #mitochondrialbiology is waiting for you here: biomed.news/bims-camemi/... @biomednews.bsky.social #keepreading
"99.9 per cent of everything you think, and of everything you do, is for yourself—and there isn't one."
-Wei Wu Wei
Thank you :)
🔦 Flash #Recherche
🧬🦀 Des scientifiques @dib-unil.bsky.social @unil.bsky.social identifient un nouveau #mécanisme susceptible de faire dérailler certains #traitements du #cancer. En jeu ? La perte du gène 𝘕𝘜𝘋𝘛5.
🔗 www.unil.ch/news/fr/1762...
@jourdainlab.bsky.social
That’s it, thanks for reading this long thread! 🙏
17/17
Also from last week, a Kubicek & Huber paper on MTHFD1 & NUDT5 👇
🔗 www.science.org/doi/10.1126/...
15/17
Published last week a new paper from Ralph DeBerardinis with really cool #purinosome imaging 🧫✨
🔗 www.science.org/doi/10.1126/...
14/17
This year, a study from J. Yang links NUDT5 to thiopurine resistance in patients:
🔗 www.jci.org/articles/vie...
13/17
Same year, a screen by J. Doench & D. Root also found NUDT5 loss → 6-TG resistance:
🔗 www.nature.com/articles/nbt...
12/17
First, a 2016 screen by N. Benvenisty showed NUDT5 loss → 6-thioguanine resistance:
🔗 www.nature.com/articles/nat...
11/17
After our bioRxiv upload in March, THREE related #NUDT5 preprints appeared on-line! 🤯
We kept in touch with the authors and tried our best to coordinate publication. Here are some links, also to older relevant papers:
10/17
Our findings link fundamental nucleotide metabolism to clinical outcomes, highlighting #NUDT5 as a biomarker for predicting therapy efficacy in cancer, autoimmune, and viral diseases.
Huge thanks to all co-authors and funders! @snsf_ch
And now, some exciting related work 👇
9/17
This led us to propose a new mechanism ⚙️
Without NUDT5, hyperactive PPAT drains PRPP into purine synthesis, with two major consequences:
1️⃣ No PRPP left for pyrimidines synthesis
2️⃣ Nucleobase analogs can’t become toxic nucleotides 💥
8/17
Purines & pyrimidines share PRPP, the sugar for de novo synthesis. In NUDT5-KO cells, we found that PRPP levels were low ⚠️
Also, we found these cells are resistant to both purine & pyrimidine nucleoBASE analogs, but not nucleoside analogs, hinting at a key metabolic shift.
7/17
We then turned to #NUDT5, not previously tied to pyrimidine metabolism.
We found that NUDT5 binds and regulates #PPAT, the rate-limiting enzyme in #purine synthesis, and this regulation is independent of its catalytic activity!
6/17
This challenges the dogma that CoQ is required for pyrimidine synthesis! And it links to recent findings on #rhodoquinone, another CoQ-like molecule in mitochondrial electron transport.
5/17
#COQ7 is essential for CoQ synthesis, so why wasn’t it a hit? 🤔
Using lipidomics & modeling, we propose that #demethoxy-CoQ, which builds up when COQ7 is lost, can accepts e⁻ from DHODH, but not from OXPHOS complexes, thus ensuring pyrimidine synthesis!
4/17
Top hits were the 3 canonical pyrimidine synthesis enzymes + #CoQ genes 🧬
But two genes stood out: COQ7, conspicuous by its absence 👀, and NUDT5, the next strongest hit after the pyrimidine enzymes.
3/17
Genes for nucleotide synthesis are essential for cell growth, unless nucleosides for salvage are provided. This gave us an idea💡
To identify new players in pyrimidine synthesis, we ran a genome-wide CRISPR-Cas9 screen in media ± uridine, a #pyrimidine #nucleoside.
2/17
Very excited to share the published version of our #uridine #CRISPR screen in naturemetabolism.bsky.social! 🎉
Led by Abigail Strefeler with @pagliarini-lab.bsky.social @zakbaker.bsky.social and team!
#NUDT5 #DMQ @dib-unil.bsky.social @fbm-unil.bsky.social
🔗 www.nature.com/articles/s42...
🧵1/17